MedTrace Logo

A Study to Evaluate the Safety and Effectiveness of TRIGEN™ INTERTAN™ (10S Models)

NCT04865146 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-02-07

No results posted yet for this study

Summary

This is a post-market study to evaluate the revision rate of femoral fractures, treated with INTERTAN 10S Nails at one-year post-operation. The study will enroll Approximately 180 subjects with femoral fractures, Approximately 7 sites are involved. The study duration will be Approximately 36 months (6 months start-up, 1 year enrollment, 1 year follow-up, 6 months closeout/study report).

Conditions

  • Femoral Fractures
  • Hip Fractures

Interventions

DEVICE

TRIGEN™ INTERTAN™

Femoral fracture treated with INTERTAN 10S Nail

Sponsors & Collaborators

  • Smith & Nephew Medical (Shanghai) Ltd

    lead INDUSTRY

Principal Investigators

  • Yuqiang Sun · Shanghai 6th People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-23
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04865146 on ClinicalTrials.gov